Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

South Korea · Delayed Price · Currency is KRW

12,820

+440 (3.55%)

At close: Jul 10, 2026

-29.56% (1Y)

Market Cap	78.24B -26.8%
Revenue (ttm)	70.93B -21.3%
Net Income	8.89B -53.2%
EPS	1,456.16 -53.2%
Shares Out	6.10M
PE Ratio	8.80
Forward PE	n/a
Dividend	850.00 (6.63%)
Ex-Dividend Date	Dec 29, 2025

Volume	1,821
Open	12,380
Previous Close	12,380
Day's Range	12,380 - 12,850
52-Week Range	12,040 - 19,250
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con... [Read more]

Industry Pharmaceutical Preparations

Founded 1945

Employees 305

Stock Exchange KOSDAQ

Ticker Symbol 009300

Full Company Profile

Financial Performance

In 2025, Sam-A Pharm.'s revenue was 77.80 billion, a decrease of -18.60% compared to the previous year's 95.58 billion. Earnings were 12.94 billion, a decrease of -41.39%.

Financial Statements